Australia markets closed

ICU Medical, Inc. (ICUI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
94.84+0.31 (+0.33%)
At close: 04:00PM EDT
94.84 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.31B
Enterprise value 3.76B
Trailing P/E N/A
Forward P/E 19.96
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.01
Price/book (mrq)1.09
Enterprise value/revenue 1.66
Enterprise value/EBITDA 14.85

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-50.20%
S&P500 52-week change 322.36%
52-week high 3212.43
52-week low 378.28
50-day moving average 3101.58
200-day moving average 3111.93

Share statistics

Avg vol (3-month) 3248.94k
Avg vol (10-day) 3151.28k
Shares outstanding 524.37M
Implied shares outstanding 624.37M
Float 821.01M
% held by insiders 112.86%
% held by institutions 189.95%
Shares short (15 Apr 2024) 41.2M
Short ratio (15 Apr 2024) 44.88
Short % of float (15 Apr 2024) 47.86%
Short % of shares outstanding (15 Apr 2024) 44.93%
Shares short (prior month 15 Mar 2024) 4959.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:2
Last split date 318 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -1.31%
Operating margin (ttm)-0.93%

Management effectiveness

Return on assets (ttm)0.67%
Return on equity (ttm)-1.41%

Income statement

Revenue (ttm)2.26B
Revenue per share (ttm)93.78
Quarterly revenue growth (yoy)1.70%
Gross profit (ttm)N/A
EBITDA 276.61M
Net income avi to common (ttm)-29.66M
Diluted EPS (ttm)-1.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)278.98M
Total cash per share (mrq)11.56
Total debt (mrq)1.7B
Total debt/equity (mrq)80.28%
Current ratio (mrq)2.54
Book value per share (mrq)87.96

Cash flow statement

Operating cash flow (ttm)166.2M
Levered free cash flow (ttm)162.25M